- $5.33bn
- $5.96bn
- $1.79bn
- 89
- 23
- 56
- 56
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,356 | 1,502 | 1,325 | 1,578 | 1,789 |
Cost of Revenue | |||||
Gross Profit | 640 | 240 | 250 | 357 | 433 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,931 | 1,488 | 1,273 | 1,403 | 1,574 |
Operating Profit | 425 | 14.1 | 51.8 | 175 | 215 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 380 | -27.7 | 22 | 150 | 110 |
Provision for Income Taxes | |||||
Net Income After Taxes | 303 | 33.3 | 17.5 | 118 | 97.6 |
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 307 | 31.7 | 16.1 | 126 | 106 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 307 | 31.7 | 16.1 | 126 | 106 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.58 | 0.825 | 0.384 | 1.56 | 1.24 |
Dividends per Share |